Slim Fourati

4.9k total citations
93 papers, 1.6k citations indexed

About

Slim Fourati is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Slim Fourati has authored 93 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Infectious Diseases, 36 papers in Epidemiology and 23 papers in Virology. Recurrent topics in Slim Fourati's work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (23 papers) and SARS-CoV-2 and COVID-19 Research (22 papers). Slim Fourati is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (23 papers) and SARS-CoV-2 and COVID-19 Research (22 papers). Slim Fourati collaborates with scholars based in France, United States and Mali. Slim Fourati's co-authors include Jean–Michel Pawlotsky, Anne‐Geneviève Marcelin, Christine Katlama, Nicolas de Prost, Vincent Cálvez, Armand Mekontso Dessap, Christophe Rodriguez, Stéphane Chevaliez, Marc Wirden and Guillaume Carteaux and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Slim Fourati

88 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Slim Fourati France	24	947	482	430	199	193	93	1.6k
Ombretta Turriziani Italy	27	1.4k 1.5×	504 1.0×	801 1.9×	212 1.1×	373 1.9×	135	2.9k
Benoît Visseaux France	24	1.3k 1.3×	685 1.4×	451 1.0×	37 0.2×	217 1.1×	122	1.9k
Mars Stone United States	30	898 0.9×	382 0.8×	394 0.9×	58 0.3×	278 1.4×	117	2.2k
Lars Heggelund Norway	23	237 0.3×	556 1.2×	157 0.4×	135 0.7×	137 0.7×	49	1.2k
Jihad Slim United States	18	847 0.9×	594 1.2×	397 0.9×	428 2.2×	87 0.5×	131	1.5k
Yang Han China	23	1.2k 1.3×	376 0.8×	487 1.1×	160 0.8×	228 1.2×	104	1.8k
Claudio Ucciferri Italy	20	376 0.4×	342 0.7×	124 0.3×	145 0.7×	216 1.1×	74	1.1k
Salvatore Casari Italy	26	807 0.9×	750 1.6×	247 0.6×	361 1.8×	67 0.3×	75	2.1k
Christa Firbas Austria	27	696 0.7×	532 1.1×	72 0.2×	168 0.8×	286 1.5×	55	1.9k
Alessandro Cozzi‐Lepri United Kingdom	23	1.3k 1.4×	513 1.1×	1.1k 2.5×	105 0.5×	87 0.5×	82	2.0k

Countries citing papers authored by Slim Fourati

Since Specialization

Citations

This map shows the geographic impact of Slim Fourati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slim Fourati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slim Fourati more than expected).

Fields of papers citing papers by Slim Fourati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Slim Fourati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slim Fourati. The network helps show where Slim Fourati may publish in the future.

Co-authorship network of co-authors of Slim Fourati

This figure shows the co-authorship network connecting the top 25 collaborators of Slim Fourati. A scholar is included among the top collaborators of Slim Fourati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Slim Fourati. Slim Fourati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gendreau, Ségolène, Pierre Cappy, Alexandra Beurton, et al.. (2025). Severe parvovirus B19 infection in patients with sickle cell disease hospitalized in intensive care units. Blood Advances. 9(22). 5695–5707.

Redjoul, Rabah, Clément Ourghanlian, Ludovic Cabanne, et al.. (2025). Respiratory Syncytial Virus Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Recipients. JAMA Network Open. 8(9). e2533828–e2533828. 1 indexed citations

Fourati, Slim, et al.. (2024). Respiratory Syncytial Virus vs Influenza Virus Infection: Mortality and Morbidity Comparison Over 7 Epidemic Seasons in an Elderly Population. The Journal of Infectious Diseases. 230(5). 1130–1138. 11 indexed citations

Enouf, Vincent, Giovanna Melica, François Lemonnier, et al.. (2024). Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine. International Journal of Infectious Diseases. 146. 107108–107108. 1 indexed citations

Bolland, William, Vincent Michel, Delphine Planas, et al.. (2023). High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1. Journal of Virology. 98(1). e0135123–e0135123. 2 indexed citations

Oubaya, Nadia, Slim Fourati, Sébastien Beaune, et al.. (2023). Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study. Clinical Microbiology and Infection. 29(7). 943.e1–943.e8. 24 indexed citations

Bastuji‐Garin, Sylvie, F. Hémery, Nadia Oubaya, et al.. (2023). The Relative Contributions of Occupational and Community Risk Factors for COVID-19 among Hospital Workers: The HOP-COVID Cohort Study. Journal of Clinical Medicine. 12(3). 1208–1208. 1 indexed citations

Feredj, E., Étienne Audureau, Vincent Fihman, et al.. (2023). Impact of a Dedicated Pretransplant Infectious Disease Consultation on Respiratory Tract Infections in Kidney Allograft Recipients: A Retrospective Study of 516 Recipients. Pathogens. 12(1). 74–74.

Razazi, Keyvan, Romain Arrestier, Guillaume Voiriot, et al.. (2023). SARS-CoV-2 variants and mutational patterns: relationship with risk of ventilator-associated pneumonia in critically ill COVID-19 patients in the era of dexamethasone. Scientific Reports. 13(1). 6658–6658. 3 indexed citations

10.

Marot, Stéphane, Isabelle Malet, Valentin Leducq, et al.. (2021). Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers. Clinical Infectious Diseases. 74(4). 707–710. 9 indexed citations

11.

Bondeelle, Louise, Maud Salmona, Jérôme LeGoff, et al.. (2021). Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients. Bone Marrow Transplantation. 56(12). 3032–3041. 11 indexed citations

12.

Fourati, Slim, Céline Langendorf, Étienne Audureau, et al.. (2021). Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use. Journal of Clinical Virology. 142. 104930–104930. 9 indexed citations

13.

Razazi, Keyvan, Romain Arrestier, Brice Benelli, et al.. (2021). Correction to: Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease. Critical Care. 25(1). 118–118. 54 indexed citations

14.

Prost, Nicolas de, Paul Bastard, Romain Arrestier, et al.. (2021). Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia. Journal of Clinical Immunology. 41(3). 536–544. 50 indexed citations

15.

Hüe, Sophie, Asma Beldi‐Ferchiou, Inès Bendib, et al.. (2020). Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 202(11). 1509–1519. 133 indexed citations

16.

Peiffer‐Smadja, Nathan, Sarah Dellière, Christophe Rodriguez, et al.. (2020). Machine learning in the clinical microbiology laboratory: has the time come for routine practice?. Clinical Microbiology and Infection. 26(10). 1300–1309. 71 indexed citations

17.

Raffetin, A., Giovanna Melica, Étienne Audureau, et al.. (2019). Molecular testing for respiratory pathogens in sickle cell disease adult patients presenting with febrile acute chest syndrome. Médecine et Maladies Infectieuses. 50(1). 49–56. 3 indexed citations

18.

Fofana, Djeneba, Cathia Soulié, Almoustapha Issiaka Maïga, et al.. (2013). Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and B. Journal of Antimicrobial Chemotherapy. 68(11). 2515–2520. 6 indexed citations

19.

Malet, Isabelle, Marc Wirden, Slim Fourati, et al.. (2011). Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients. Journal of Antimicrobial Chemotherapy. 66(7). 1481–1483. 16 indexed citations

20.

Malet, Isabelle, Slim Fourati, Charlotte Charpentier, et al.. (2011). The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype. Journal of Antimicrobial Chemotherapy. 66(12). 2827–2830. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact